Losartan Lawsuit Lawyer

Losartan Class Actions & Individual Lawsuits

Losartan lawsuits have been arising alleging injury from use of Losartan to treat high blood pressure (hypertension).  If you have been diagnosed with cancer of the lungs, kidneys or liver or sustained liver damage following the use of Losartan, a Losartan lawsuit attorney be able to help.  Call us today to learn more about your right to file a Losartan lawsuit.

There have been 9 separate voluntary recalls of lots of Losartan due to the discovery of elevated levels of N-nitrosodiethylamine (NDEA)–a probable human carcinogen. If you or your spouse were diagnosed with a cancerous tumor and/or liver damage following the use of Losartan, call Simmons and Fletcher, P.C. at 1-800-298-0111.

What is Losartan?

Losartan is an angiotensin II receptor blocker (ARB) that is used to treat high blood pressure (hypertension) by relaxing the blood vessels.  It is a prescription medication and is not available over the counter in any way, shape or form. There are alternative medications to Losartan available.  You should discuss the alternatives with your physician before discontinuing use of any prescription medication and do so immediately.

What is N-nitrosodiethylamine (NDEA)?

The Environmental Protection Agency defines NDEA as a Group B2, probable human carcinogen while they do not have data regarding the effects on humans, it has been associated with an increased incidence of tumors in rats in the lungs, kidneys and liver following chronic ingestion and/or inhalation.  It is currently believed to be a byproduct of the manufacturing process of Losartan when certain chemicals are present and/or currently defined manufacturing processes are not followed.

Injuries Linked to NDEA Exposure

Prolonged exposure to elevated levels of NDEA may increase your risk of developing the following:

  • Lung cancer
  • Kidney cancer
  • Liver cancer

Additionally, liver damage and low platelet counts may result from exposure.  Symptoms of liver damage include:

  • Nausea
  • Vomiting
  • Headaches
  • Malaise

Losartan Recall History

At the present time, the FDA has not recalled all Losartan medications. Since November of 2018, several manufactures have voluntarily recalled specific batches of Losartan that were later determined to have elevated levels of NDEA,  The Losartan recall history is as follows:

  • November 8, 2018 – Sandoz, Inc. – recalls a single lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg.
  • December 20, 2018 – Torrent Pharmaceuticals Limited issues a  voluntarily recall of 2 lots of Losartan potassium tablets.
  • January 3, 2019 – Torrent Pharmaceuticals Limited voluntary recalls 8 more lots of Losartan potassium tablets USP.
  • January 22, 2019 – Torrent Pharmaceuticals Limited adds 6 more lots to the recall.
  • February 22, 2019 – Macleods Pharmaceuticals Limited voluntarily recalls a single lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg.
  • February 28, 2019 – Hetero Labs Ltd. and Camber Pharmaceuticals, Inc. recalls 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg.
  • March 1, 2019 – Torrent Pharmaceuticals Limited recalls 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/ hydrochlorothiazide tablets due to a finding of N-Methylnitrosobutyric acid (NMBA) above the acceptable daily intake levels.
  • April 18, 2019 – Torrent Pharmaceuticals Limited expands the recall to include an additional 36 lots of Losartan potassium Tablets USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP.
  • April 24, 2019 – Legacy Pharmaceutical Packaging, LLC adds one additional lot to recall of its  Losartan Tablets USP 50mg.

A consolidated list of recalled lots can be found on the FDA recall update page.

Attorneys for Losartan Claims

The losartan lawsuits are closely related to the valsartan lawsuits.  Recently, the valsartan cases in Federal Court were consolidated into MDL 19-2875 in the United States District Court for the District of New Jersey Camden Vicinage.  The Court has not decided whether losartan cases will be consolidated into the same proceedings.  If so, deadlines for filing claims will likely be set by the Court. As a result, it is important that you protect your rights by seeking counsel regarding your losartan claim as soon as possible.  Call Simmons and Fletcher, P.C. to discuss your options today: 1-800-298-0111.

Warning: Never discontinue taking any prescribed medication without consulting your licensed physician.